Absolute quantification of swine brain Glutamate compounds concentration using MR spectroscopy and LCModel after nasal spraying butorphanol tartrate

BioMedical Engineering and Informatics: New Development and the Future - Proceedings of the 1st International Conference on BioMedical Engineering and Informatics, BMEI 2008

Volumn 2, Issue , 2008, Pages 348-352

  Wu, J L ^a   Liu, T ^a   Lin, Y ^b   Shen, Z W ^b   Miao, Y W ^a   Wu, R H ^b   Lang, Z J ^a  

^a Department of Dermatology and Venereology   (China)

^b SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Absolute quantification; Glutamate Glutamine; LCModel; Nasal spraying; Proton magnetic resonance spectroscopy

Indexed keywords

ARSENIC COMPOUNDS; COMPUTER NETWORKS; CONCENTRATION (PROCESS); MAGNETIC RESONANCE SPECTROSCOPY; NUCLEAR MAGNETIC RESONANCE; PESTICIDES; PROTONS; RESONANCE; SPRAYING;

ABSOLUTE QUANTIFICATION; GLUTAMATE/GLUTAMINE; LCMODEL; NASAL SPRAYING; PROTON MAGNETIC RESONANCE SPECTROSCOPY;

BIOPHYSICS;

EID: 51649098504     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/BMEI.2008.96     Document Type: Conference Paper

References (25)

1. L. Illum, "Transport of drugs from the nasal cavity to the central nervous systerms", Eur J Pharmacol, 2000, 11(1) 1-18.
2. L. Illum, "Nasal drug delivery: new development and strategies", Drugdiscov Today, 2002, 7(23), 1184-1189.
3. H.L. Fields, "State-dependent opioid control of pain", Nat Rev Neurosci, 2004(5).565-575.
4. S.E. Hemby, T.R. Koves, J.E. Smith, S.I. Dworkin, "Differences in extracellular dopamine concentrations in the nucleus accumbens during response-dependent and responseindependent cocaine administration in the rat", Psychopharmacology (Berl), 1997, 133.7-16.
5. J.M. Wilson, J.N. Nobrega, W.A. Corrigal, K.M. Coen, K Shannak, S.J. Kish, "Amygdala dopamine levels are markedly elevated after self-but not passive-administration of cocaine", Brain Res, 1994, 668.39-45.
6. R. Stefanski, B. Ladenheim, S.H. Lee, J.L. Cadet, S.R. Goldberg, "Neuroadaptations in the dopaminergic system after active self-administration but not after passive administration of methamphetamine", Eur J Pharmacol 1999, 371, 123-135.
7. J.A. Stamford, D. Rickwood and B.D. Hames, Monitoring Neuronal Activity: A Practical Approach, Oxford, UK: IRL Press at Oxford University Press, The Practical Approach Series, 1992.
8. C.L. Graff, G.M. Pollack, "Nasal drug administration: potential for targeted central nervous system delivery", J Pharm Sci, 2005, Jun. 94(6). 1187-95.
9. A.J. Ross, P.S. Sachdev, "Magnetic resonance spectroscopy in cognitive research", Brain Res, 2004, 44. 83-102.
10. A. Di Costanzo, F. Trojsi, M. Tosetti, G.M. Giannatempo, F. Nemore, M. Piccirillo, S. Bonavita, G. Tedeschi, T. Scarabino, "High-field proton MRS of human brain", Eur J Radiol, 2003, 48.146-153.
11. ID. Grachev, B.E. Fredrickson, A.V. Apkarian, "Abnormal brain chemistry in chronic back pain: an in vivo proton magnetic resonance spectroscopy study", Pain, 2000, 89, 7-18.
12. M.C. Tartaglia, S. Narayanan, D.N. Stefano, "Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis" J Neurol, 2002, 249.1382-1390.
13. D.N. Stefano, S. Narayanan, S.J. Francis, "Diffuse axonal and tissue injury in patients with multiple sclerosis with low cerebral lesion load and no disability", Arch Neurol, 2002, 59. 1565-1571.
14. S.W. Provencher, "Automatic quantitation of localized in vivo 1H spectra with LCModel", NMR in biomedicine, 2001, 14. 260-264.
15. J.C. Watkins, R.H. Evans. "Excitatory amino acid transmitters", Ann Rev Pharmacol Toxicol, 1981, 21.165-204.
16. G.L. Collingridge, R.A. Lester, "Excitatory amino acid receptors in the vertebrate central nervous system", Pharmacol Rev, 1989, 40, 143-209.
17. R. Silva, L. Mata, S. Gulbenkian, "Inhibition of glutamate uptake by unconjugated bilirubin in cultured cortical rat astrocytesxole of concentration and pH", Biochem Biophys Res Comm 1999, 265.67-72.
18. L.M. Aanonsen, S Lei, G.L. Wilcox, "Excitatory amino acid receptors and nociceptive neurotransmission in rat spinal cord", Pain, 1990, 41. 309-321.
19. J. Theberge, R. Bartha, D.J. Drost, R.S. Menon, A. Malla, J. Takhar, R.W. Neufeld, J. Rogers, W. Pavlosky, B. Schaefer, M. Densmore, P.C. Al-Seminaan Y. Williamson, "Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers", Am J Psychiatry 2002, 159.1944-1946.
20. S.W. Provencher, "Estimation of metabolite concentrations from localized in vivo proton NMR spectra", Magn Reson Med, 1993, 30(6).672-679.
21. F.G. Woermannl, M.A. Mclean, "Quantitative short echo time proton magnetic resonance spectroscopic imaging study of malformations of cortical development causing epilepsy", Brain, 2001, 124.427-436.
22. J. Dong-Pyo, "Interindividual Reproducibility of Glutamate Quantification using 1.5-T Proton Magnetic Resonance Spectroscopy", Magnetic Resonance in Medicine 2005, 53.708-712.
23. J. Pfeuffer, I. Tkac, S.W. Provencher, R. Gruetter, "Toward an in vivo neurochemical profile: quantification of 18 metabolites in short-echo-time (1)H-NMR spectra of the rat brain", Magn Reson Med, 1999, 141.104-120.
24. J. Stanley, D.J. Drost, P.C. Williamson, R.T. Thompson, "The use of a priori knowledge to quantify short echo in vivo 1H MR spectra", Magn Reson Med, 1995, 34.17-24.
25. R. Bartha, Y.M. al-Seminaan, P.C. Williamson, D.J. Drost, A.K. Malla, T.J. Carr, M. Densmore, G. Canaran, R.W. Neufeld, "A short echo proton magnetic resonance spectroscopy study of the left mesial-temporal lobe in firstonset schizophrenic patients", Biol Psychiatry, 1999, 45.1403-1411.